excess deaths in japan after covid jabs

Here in the USA ....... can we get any honest answers?

You crazy. Remember how bad the govt wanted to inject you with that snake juice, free donuts for a month, a chance to win toilet tissue for a lifetime, lottery tickets, a month of free lap dances, 500 free lotto tickets, etc.........................
 
You crazy. Remember how bad the govt wanted to inject you with that snake juice, free donuts for a month, a chance to win toilet tissue for a lifetime, lottery tickets, a month of free lap dances, 500 free lotto tickets, etc.........................
What an ass. You are on Ignore for this thread. You are a loony, period.
 


not surprising.

According to the authors, political party affiliation in Ohio was defined by whether an individual voted in a party’s primary election within the preceding 2 calendar years, and in Florida, political party affiliation was based on party registration.

15% higher excess deaths among Republicans
In general, there was a 20.5 percentage-point (95% prediction interval [PI], 15.6 to 25.6 percentage points) increase in weekly death counts in Florida and Ohio between March 2020 and December 2021. Excess death rates were 2.8 percentage points (15%) higher for Republican voters compared with Democratic voters (95% PI, 1.6 to 3.7 percentage points).

The higher excess death rate observed among Republican voters may continue through subsequent stages of the pandemic.
After May of 2021, roughly 1 month after COVID-19 vaccines became widely available, the gap between Republicans and Democrats further widened, to 7.7 percentage points (95% PI, 6.0 to 9.3 percentage points) in the adjusted analysis, or a 43% difference, the authors said. The difference was seen in Florida, but was most pronounced in Ohio
 
Yes, the vaccine was safe.

Far more have been saved then were ever injured much less killed by it.

No major scientific, infectious disease, or major medical website agrees with the conspiracy nonsense.

Yet we now have RFK Junior as our HHS secretary. The eyes bulge.

And no reader should be startled that more Republicans died in 2021 than Democrats by a two to 1 margin.
 


not surprising.

To contextualise the incidence of myocarditis after COVID‐19 vaccination, it is helpful to compare the risk to the incidence of myocarditis after influenza vaccination or SARS‐CoV‐2 infection. Myocarditis is typically not associated with influenza vaccination; thus, there are few, if any reports describing the incidence. On the contrary, myocarditis is a known cardiovascular sequala of COVID‐19. 13 The CDC estimated that among men 12–17 and 18–29, the incidence of myocarditis and myocarditis or pericarditis was 50.1–64.9 and 55.3–100.6 cases per 100,000, respectively. 13 The incidence of myocarditis found for young men after SARS‐CoV‐2 infection is larger than what we found for myocarditis following COVID‐19 vaccination
 


not surprising.

Studies typically rely on documented infections, which likely suffers the flaw of undercounting the total number of infections because not everyone with the infection has a documented positive test. Thus, the incidence may be inflated and inaccurate. Using seroprevalence data as opposed to documented infections would better capture the total number of infections in a given population, and would more accurately estimate myocarditis post infection
 


not surprising.

However, when Patone's analysis was limited to those under 40, the number of excess myocarditis events after dose 2 of the Moderna vaccine outnumbered those having had a SARS‐CoV‐2 infection. 14 Furthermore, calculating the incidence of myocarditis after vaccination is relatively precise given that the two inputs, cases of myocarditis and vaccine doses administered, are known. The calculation for estimating the incidence of myocarditis after SARS‐CoV‐2 infection is more challenging to obtain because the total number of people who have had an infection is likely unknown and unattainable. Studies typically rely on documented infections, which likely suffers the flaw of undercounting the total number of infections because not everyone with the infection has a documented positive test. Thus, the incidence may be inflated and inaccurate. Using seroprevalence data as opposed to documented infections would better capture the total number of infections in a given population, and would more accurately estimate myocarditis post infection
 
However, when Patone's analysis was limited to those under 40, the number of excess myocarditis events after dose 2 of the Moderna vaccine outnumbered those having had a SARS‐CoV‐2 infection. 14 Furthermore, calculating the incidence of myocarditis after vaccination is relatively precise given that the two inputs, cases of myocarditis and vaccine doses administered, are known. The calculation for estimating the incidence of myocarditis after SARS‐CoV‐2 infection is more challenging to obtain because the total number of people who have had an infection is likely unknown and unattainable. Studies typically rely on documented infections, which likely suffers the flaw of undercounting the total number of infections because not everyone with the infection has a documented positive test. Thus, the incidence may be inflated and inaccurate. Using seroprevalence data as opposed to documented infections would better capture the total number of infections in a given population, and would more accurately estimate myocarditis post infection
 


not surprising.

5. CONCLUSION
Myocarditis is a serious adverse event that disproportionately affects men under 40, with highest risk among men aged 12–24 who receive a second dose of a COVID‐19 mRNA vaccine. We show that when investigators present the risk of myocarditis stratified by sex, age, dose number and manufacturer, it is much larger than without stratification. An important safety signal may have been ignored or minimised by failure to stratify appropriately
 
5. CONCLUSION
Myocarditis is a serious adverse event that disproportionately affects men under 40, with highest risk among men aged 12–24 who receive a second dose of a COVID‐19 mRNA vaccine. We show that when investigators present the risk of myocarditis stratified by sex, age, dose number and manufacturer, it is much larger than without stratification. An important safety signal may have been ignored or minimised by failure to stratify appropriately
 
15th post


not surprising.

A total of 40,901 people died in motor vehicle crashes in 2023. The U.S. Department of Transportation’s most recent estimate of the annual economic cost of crashes is $340 billion (Blincoe et al., 2023). Contributing to the death toll are alcohol, speeding, lack of seat belt use and other problematic behaviors. Death rates vary by vehicle type, driver age and sex, and other factors
 
A total of 40,901 people died in motor vehicle crashes in 2023. The U.S. Department of Transportation’s most recent estimate of the annual economic cost of crashes is $340 billion (Blincoe et al., 2023). Contributing to the death toll are alcohol, speeding, lack of seat belt use and other problematic behaviors. Death rates vary by vehicle type, driver age and sex, and other factors
 
Hospitalization for other cardiovascular conditions occurred in 2.7% of patients with postvaccination myocarditis, in 7.4% of those with post-infection myocarditis, and in 7.3% of patients who had conventional cases. One patient (0.2%) died after postvaccine myocarditis, 4 (1.3%) died after post-COVID myocarditis, and 49 (1.3%) died after the conventional condition
 
Back
Top Bottom